Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme. Pesque D, Tormo-Mainar S, Bach R, Recuero-Borau J, et al. Int J Dermatol 2022;61:e407-e408.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pesque D, Tormo-Mainar S, Bach R, Recuero-Borau J, et al. Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme. Int J Dermatol 2022;61:e407-e408.
PMID: 35080014